Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Effect of Vitamin D Replacement on Tumor Response and Survival Parameters for Vitamin D Insufficient Patients With Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01787409
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:44.193216+00:00
Published At
2025-12-30T00:00:00+00:00
Record Updated At
2025-12-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Aggressive Non-Hodgkin Lymphoma", "Anaplastic Large Cell Lymphoma", "Angioimmunoblastic T-Cell Lymphoma", "Chronic Lymphocytic Leukemia", "Diffuse Large B-Cell Lymphoma", "Enteropathy-Associated T-Cell Lymphoma", "Hepatosplenic T-Cell Lymphoma", "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "Mediastinal (Thymic) Large B-Cell Lymphoma", "Nasal Type Extranodal NK/T-Cell Lymphoma", "Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Primary Cutaneous Anaplastic Large Cell Lymphoma", "Refractory Anaplastic Large Cell Lymphoma", "Small Lymphocytic Lymphoma", "Subcutaneous Panniculitis-Like T-Cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-30"
protocolSection.identificationModule.nctId
"NCT01787409"
protocolSection.identificationModule.officialTitle
"Effect of Vitamin D Replacement on Tumor Response and Survival Parameters for Vitamin D Insufficient Patients With Cancer"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Aggressive Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Angioimmunoblastic T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Diffuse Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Enteropathy-Associated T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Hepatosplenic T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Mediastinal (Thymic) Large B-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Nasal Type Extranodal NK/T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified (protocolSection.conditionsModule.conditions)
  • Primary Cutaneous Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Subcutaneous Panniculitis-Like T-Cell Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.